![]() |
|
|
Vol. 281, Issue 1, 549-557, 1997
Neurofarmacología, Instituto de Neurobiología
Santiago Ramón y Cajal, Consejo Superior de Investigaciones
Científicas. Avenida Doctor Arce 37, 28002 Madrid, Spain
A nonisotopic, immunoelectrophoretic technique was used to analyze the
characteristics of opioid-evoked activation of
Gi2/Gx/z transducer proteins of mouse
periaqueductal gray matter membranes. In the presence of picomolar
concentrations of guanosine 5
-O-(3-thiotriphosphate), the opioid
agonists promoted concentration-dependent increases of immunoreactivity
associated with free Gi2
and Gx/z
subunits. [D-Ala2,N-MePhe4,Gly-ol5]enkephalin
and morphine (preferential agonists at mu opioid
receptors) and
-endorphin-(1-31) (an agonist at
mu/delta opioid receptors) activated Gx/z
proteins. In contrast, the agonists of delta opioid receptors, [D-Ala2]deltorphin II and
[D-Pen2,5]enkephalin, displayed little or no
activity on this pertussis toxin resistant regulatory protein. Although
exhibiting diverse efficacy, all the opioids studied activated
Gi2 transducer proteins. [D-Ala2,N-MePhe4,Gly-ol5]enkephalin
and [D-Ala2]deltorphin II were more
potent at Gi2
subunits than at Gx/z
subunits. The opioid antagonist naloxone displayed a competitive profile in reducing the activation of G proteins promoted by
morphine. Moreover, [D-Pen2,5]enkephalin
antagonized the releasing effect exerted by
[D-Ala2]deltorphin II on Gi2
and Gx/z
subunits.
N,N-diallyl-Tyr-Aib-Aib-Phe-Leu (ICI-174864) reduced the G
-related immunosignals promoted by agonists of delta opioid receptors. Therefore, it is
suggested that opioids exhibit marked differences in efficacy and/or
potency in the activation of Gi2 and Gx/z
transducer proteins in mouse periaqueductal gray matter.
This article has been cited by other articles:
![]() |
E. Morou and Z. Georgoussi Expression of the Third Intracellular Loop of the {delta}-Opioid Receptor Inhibits Signaling by Opioid Receptors and Other G Protein-Coupled Receptors J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1368 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sánchez-Blázquez, M. Rodríguez-Díaz, I. DeAntonio, and J. Garzón Endomorphin-1 and Endomorphin-2 Show Differences in Their Activation of {micro} Opioid Receptor-Regulated G Proteins in Supraspinal Antinociception in Mice J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 12 - 18. [Abstract] [Full Text] |
||||
![]() |
G. Bot, A. D. Blake, S. Li, and T. Reisine Fentanyl and its Analogs Desensitize the Cloned Mu Opioid Receptor J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1207 - 1218. [Abstract] [Full Text] |
||||
![]() |
P. Sánchez-Blázquez and J. Garzón Delta Opioid Receptor Subtypes Activate Inositol-Signaling Pathways in the Production of Antinociception J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 820 - 827. [Abstract] [Full Text] |
||||
![]() |
G. Bot, A. D. Blake, S. Li, and T. Reisine Mutagenesis of the Mouse Delta Opioid Receptor Converts (-)-Buprenorphine from a Partial Agonist to an Antagonist J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 283 - 290. [Abstract] [Full Text] |
||||